What is the stance of CSL as a corporation? Do they aim to maximize profits, or create shared value, or hold a corporate social responsibility? Have they kept their promise in saving lives and finding cures?

CSL Plasma runs its daily business operations based on business pillars that include People and Culture, Innovation, Efficiency, Influenza, Growth, and Shared Value. As one of the largest plasma collection companies in the world, CSL Plasma has upheld its promise to save lives through innovative medical research and the development of powerful influenza and cardiac therapies and treatments as well as direct plasma donations to hospitalized patients.

Expert Answers

An illustration of the letter 'A' in a speech bubbles

CSL Plasma is one of the largest and most innovative plasma collection companies in the world. CSL Plasma has over 275 plasma collection facilities in the United States, Europe, and China, and it employs more than 12,000 employees. Plasma donations made through CSL Plasma benefit citizens from approximately 75 countries...

See
This Answer Now

Start your 48-hour free trial to unlock this answer and thousands more. Enjoy eNotes ad-free and cancel anytime.

Get 48 Hours Free Access

CSL Plasma is one of the largest and most innovative plasma collection companies in the world. CSL Plasma has over 275 plasma collection facilities in the United States, Europe, and China, and it employs more than 12,000 employees. Plasma donations made through CSL Plasma benefit citizens from approximately 75 countries throughout the world. CSL Plasma has a series of business pillars that they stand by and strive to follow during daily business operations. These business pillars include:

  1. People and Culture. CSL Plasma promises to be inclusive relating to gender and race during its hiring practices while attracting and retaining top talent. Currently, 57% of the company's workforce is female. There is also a strong focus on workplace safety with continuous improvement practices in place.
  2. Innovation. CSL Plasma promises to pursue new opportunities for research and innovation in order to provide life saving treatments to people across the world. CSL Plasma recently opened a new Bio21 medical research facility in Melbourne, Australia.
  3. Efficiency. CSL Plasma promises to run its operations in an efficient manner. The company recently opened 30 new plasma collection facilities across the United States. The company has major capital projects occurring in many of its locations to accommodate growing demand.
  4. Influenza. CSL Plasma promises to focus its medical research on influenza treatments, with a focus on older, more vulnerable senior citizens. Currently, the company has helped develop 3 influenza treatments (Seqirus, FLUAD, FLUCELVAX).
  5. Growth and Shared Value. CSL Plasma promises company growth in order to maximize revenue; this revenue is promised to be shared with employees through wages and benefits, stakeholders through returns, the government through taxes, and the community through contributions and integration.

CSL Plasma has upheld its promise to save lives through utilizing plasma donations to develop treatment through medical research as well as directly benefiting patients in hospitals throughout the world.

Approved by eNotes Editorial Team